Growth deceleration in a girl treated with imatinib

Int J Hematol. 2009 Mar;89(2):251-252. doi: 10.1007/s12185-008-0251-8. Epub 2009 Jan 20.

Authors

Tomiko Kimoto¹, Masami Inoue², Keisei Kawa²

Affiliations

¹ Department of Hematology/Oncology, Osaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodo-cho, Izumi, Osaka, 594-1101, Japan. [email protected].
² Department of Hematology/Oncology, Osaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodo-cho, Izumi, Osaka, 594-1101, Japan.

PMID: 19152100
DOI: 10.1007/s12185-008-0251-8

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Benzamides
Bone Density / drug effects
Bone Development / drug effects
Child
Female
Growth / drug effects*
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / physiopathology*
Piperazines / adverse effects*
Pyrimidines / adverse effects*

Substances

Benzamides
Piperazines
Pyrimidines
Imatinib Mesylate